FDA Approves New Type of Anti-Clotting Drug
Zontivity, which belongs to a novel class of drugs, reduced heart, stroke, cardiovascular death in patientsContinue Reading
Zontivity, which belongs to a novel class of drugs, reduced heart, stroke, cardiovascular death in patientsContinue Reading
Drug designed to reduce blood clotsContinue Reading
Drug designed to reduce blood clotsContinue Reading
Aim for at least four to five a day, experts adviseContinue Reading
Aim for at least four to five a day, experts adviseContinue Reading
Electrocardiogram might help identify teens at risk of sudden deathContinue Reading
So-called ‘bariatric’ procedures appear to cut risk of atrial fibrillation, researchers reportContinue Reading
Experts suggest ways to keep high blood pressure under controlContinue Reading
It may cause more harm than good in those who have not experienced heart problems or strokeContinue Reading
Scientists say HRT research has returned $140 for every $1 spent on the $260 million trialContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.